Scarica l'app Stockscreener
6.275
2.71%
-0.1749
Precedente Chiudi:
$6.4499
Aprire:
$6.4
Volume 24 ore:
6,961
Relative Volume:
4.03
Capitalizzazione di mercato:
$N/A
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+7.26%
1M Prestazione:
+0.00%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$6.00
$6.40
Intervallo di 1 settimana:
$5.85
$6.70
Portata 52W:
$5.85
$6.72
Bioharvest Sciences Inc Stock (BHST) Company Profile
Nome
Bioharvest Sciences Inc
Settore
Industria
Telefono
-
Indirizzo
-
Confronta BHST con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
| BHST | 6.18 | 0 | 0 | 0 | 0 | 0.00 |
| VRTX | 448.50 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 746.23 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 597.88 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 246.48 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 108.11 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
Bioharvest Sciences Inc Borsa (BHST) Ultime notizie
BioHarvest Sciences to Present Growth Strategy at Noble Capital Markets Conference | BHST Stock News - StockTitan
CNVCF (BioHarvest Sciences) GF Value Rank : 2 (As of Nov. 21, 2024) - GuruFocus.com
Ilan Sobel, CEO of BioHarvest Sciences - iHeart
BioHarvest Sciences to Announce Q3 2024 Results - TipRanks
BioHarvest Sciences to Host Third Quarter 2024 Earnings Call on November 25 at 4:30 P.M. Eastern Time - The Kingston Whig-Standard
BioHarvest Sciences Sets Q3 2024 Earnings Call for November 25 | BHST Stock News - StockTitan
Revenues Tell The Story For BioHarvest Sciences Inc. (CSE:BHSC) As Its Stock Soars 26% - Simply Wall St
BioHarvest shares rise in Nasdaq debut - Proactive Investors USA
BioHarvest Sciences Begins Nasdaq Trading - TipRanks
BioHarvest Sciences Begins Trading on the Nasdaq Global Market - Newsfile
BioHarvest Sciences (BHST) Debuts on Nasdaq Global Market, Sets Q3 Earnings Date | BHST Stock News - StockTitan
BioHarvest Sciences Uplists to Nasdaq, Expanding Shareholder Base - TipRanks
Canada Market’s top losers: Enterprise Group-14.16%, BioHarvest Sciences -12.34% - Business Upturn
BioHarvest Sciences shares to list on Nasdaq next week - Proactive Investors Australia
BioHarvest Sciences Announces Uplisting to the Nasdaq Global Market - StockTitan
BioHarvest Sciences set to begin trading on Nasdaq, marking major milestone in U.S. market expansion - Proactive Investors USA
BioHarvest Sciences appoints new CFO - Proactive Investors UK
BioHarvest Sciences Announces Record Preliminary Third Quarter 2024 Financial Results - Yahoo Finance
BioHarvest Sciences to Participate in LD Micro Main Event XVII Conference on October 30, 2024 - Yahoo Finance
BioHarvest Sciences Reports Director's Ongoing Key Role Following Resignation from Board - StockTitan
BioHarvest Sciences to Participate in iAccess Alpha Buyside Best Ideas Conference on September 24-25, 2024 - Newsfile
BioHarvest Sciences to Showcase at Global Investment Conference - TipRanks
BioHarvest Sciences Second Quarter 2024 Earnings: US$0.042 loss per share (vs US$0.21 loss in 2Q 2023) - Simply Wall St
BioHarvest Sciences Appoints Anna Tenstam as VP of Business Development, Cosmeceuticals and Injectables - Newsfile
BioHarvest Sciences hits sales milestone for VINIA Superfood Coffee - Proactive Investors USA
BioHarvest Sciences closes first tranche of private placement - Proactive Investors UK
BioHarvest Sciences Announces a Private Placement of up to USD $5 Million and Conversion of Debt Notes - Yahoo Finance
BioHarvest Sciences Announces Record $2 Million Monthly Sales - Yahoo Finance
BioHarvest Sciences Reports First Quarter 2024 Financial Results - StreetInsider.com
BioHarvest Sciences Announces New Strategic Hires for CDMO Services Business Unit - BioSpace
BioHarvest Sciences launches contract development and manufacturing organization business unit - Proactive Investors UK
BioHarvest Sciences to Present at the 2024 BIO CEO & Investor Conference By Investing.com - Investing.com Canada
BioHarvest Issues 2023 Year End Shareholder Letter and Provides Corporate Update - Financial Content
BioHarvest Sciences Inc. Closes Final Tranche of Oversubscribed $13.5M Private Placement - StockTitan
BioHarvest Sciences Announces Major Product Launch of VINIA-Based Functional Coffees - Nasdaq
BioHarvest Sciences Reports Q3 2023 Revenue Demonstrating Continued Growth Momentum - StockTitan
BioHarvest Sciences congratulates ‘Team VINIA’ NFL prospects on draft success - Proactive Investors UK
BioHarvest Introduces its 1st Cannabis Breakthrough Composition with Major Medical and Commercial Implications - BioSpace
CSE Bulletin: INDEXCSE 25 Index Quarterly Rebalancing - Investing News Network
BioHarvest Sciences Hires Dr. Brian S. Cornblatt as Chief Medical Officer - Investing News Network
BioHarvest Sciences Unveils Profile of Unique Cannabis Composition - Investing News Network
BioHarvest Sciences Inc. Quarterly Shareholder Update Live Event April 7, 2022, at 2:00 PM E.T. - Investing News Network
Bioharvest Sciences Inc. Reports Strong Q1 2022 Results on All of the Company's Activities - Investing News Network
Bioharvest Sciences Inc. Successfully Completes Cannabis R&D Program - Investing News Network
BioHarvest Sciences says it has produced cannabis biomass in large-scale industrial bioreactors - Proactive Investors UK
BioHarvest CEO Ilan Sobel: Disrupting Industries with Unique Products and Therapeutic Solutions - Investing News Network
BioHarvest Sciences Inc. Trademarks Its Breakthrough Non-GMO Proven Platform Technology: "BIO-PLANT CELLicitation" - Investing News Network
BioHarvest Sciences Inc. Engages Thunder11 as a Public Relations Agency of Record - Investing News Network
BioHarvest Sciences Inc. to Present at BIO CEO & Investor Conference in New York City on February 14-17, 2022 - Investing News Network
BioHarvest Sciences Inc. Projects 2022 Revenue to Grow 2.5X-3.5X to a Range of USD $5M-$7M - Investing News Network
BioHarvest Sciences Inc. Plans to Build a Production Facility in Ontario to Serve the Canadian Market with Unique Cannabis Products - Investing News Network
Bioharvest Sciences Inc Azioni (BHST) Dati Finanziari
Non sono disponibili dati finanziari per Bioharvest Sciences Inc (BHST). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
1.80%
0.42%
Capitalizzazione:
|
Volume (24 ore):